By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Matinas BioPharma 

915 Klosterman Road East

Tarpon Springs  Florida  34689  U.S.A.
Phone: 1-908-443-1860 Fax: n/a


Company News
Matinas BioPharma Presents Pre-Clinical Data Showing Anti-Bacterial Activity Of MAT2501 - Encochleated Amikacin - Against Mycobacterium Avium Lung Infections At ICAAC/ICC 2015 9/21/2015 8:04:01 AM
Matinas BioPharma's MAT2203 -- Encochleated Formulation Of Amphotericin B -- Shows Potential To Target And Penetrate Tissue Infected With Invasive Candidiasis In Data Presented At ICAAC/ICC 2015 9/21/2015 7:20:22 AM
Matinas BioPharma Appoints International Expert And Thought Leader On Invasive Fungal Infections Peter G. Pappas, M.D., FACP, To Scientific Advisory Board 9/17/2015 11:43:55 AM
Matinas BioPharma To Present At The 17th Annual Rodman & Renshaw Global Investment Conference On September 9, 2015 9/2/2015 8:14:27 AM
Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., As Senior Vice President And Chief Technology Officer 9/1/2015 7:22:08 AM
Matinas BioPharma's Lead Antifungal Product Candidate MAT2203 Granted QIDP And Fast Track Designations By FDA 8/18/2015 8:15:22 AM
Matinas BioPharma Announces Abstract On Pharmacokinetics And Efficacy Of Encochleated Atovaquone In Murine Model Of Pneumocystis Accepted For Oral Presentation At IDWeek 2015 7/27/2015 7:26:52 AM
Matinas BioPharma Appoints Infectious Diseases Expert, David S. Perlin, Ph.D., To Scientific Advisory Board 7/23/2015 8:30:21 AM
Matinas BioPharma Announces Two Abstracts Accepted For Presentation On Preclinical Data Of Lead Anti-Infective Product Candidates MAT2203 And MAT2501 At ICAAC/ICC 2015 7/14/2015 7:46:19 AM
Matinas BioPharma To Present At The 12th Anti-Infectives Partnering And Deal Making Conference 7/7/2015 7:21:48 AM